AU2021900689A0 - Improved vaccine composition - Google Patents

Improved vaccine composition

Info

Publication number
AU2021900689A0
AU2021900689A0 AU2021900689A AU2021900689A AU2021900689A0 AU 2021900689 A0 AU2021900689 A0 AU 2021900689A0 AU 2021900689 A AU2021900689 A AU 2021900689A AU 2021900689 A AU2021900689 A AU 2021900689A AU 2021900689 A0 AU2021900689 A0 AU 2021900689A0
Authority
AU
Australia
Prior art keywords
vaccine composition
improved vaccine
improved
composition
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021900689A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ena Respiratory Pty Ltd
Original Assignee
Ena Respiratory Pty Ltd
Filing date
Publication date
Application filed by Ena Respiratory Pty Ltd filed Critical Ena Respiratory Pty Ltd
Publication of AU2021900689A0 publication Critical patent/AU2021900689A0/en
Pending legal-status Critical Current

Links

AU2021900689A 2021-03-10 Improved vaccine composition Pending AU2021900689A0 (en)

Publications (1)

Publication Number Publication Date
AU2021900689A0 true AU2021900689A0 (en) 2021-03-25

Family

ID=

Similar Documents

Publication Publication Date Title
EP4148096A4 (en) Composition
EP3871694A4 (en) Composition
EP4043002A4 (en) Dental composition
EP3541419A4 (en) Immunogenic composition for mers coronavirus infection
SG10202104508YA (en) Immunogenic composition
EP3989959A4 (en) Transdermal formulations
EP3954721A4 (en) Composition
EP4007590A4 (en) Formulations including dihydrohonokiol
EP3981256A4 (en) Composition
EP3941942A4 (en) Composition
EP3741388A4 (en) Immunogenic composition
EP3984549A4 (en) Medicinal composition
EP3949952A4 (en) Medicinal composition
EP3985062A4 (en) Composition
EP4013441A4 (en) Larazotide formulations
EP3964264A4 (en) Novel pharmaceutical composition
AU2021900689A0 (en) Improved vaccine composition
AU2021902566A0 (en) Vaccine compositions
AU2021901392A0 (en) Immunogenic composition
AU2021903076A0 (en) SARS-CoV2 Vaccine
AU2020902779A0 (en) Immunogenic Compositions
GB202013262D0 (en) Vaccine Composition
EP4021491A4 (en) Antimicrobial vaccine compositions
EP3764991A4 (en) Vaccine composition
AU2022362630A1 (en) Composition